How Smartphone Swabs May Offer Convenient Toxicology Testing
A new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
A new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
Verichem Laboratories upgraded its web-based, CLIA-compliant data reduction and test reporting software program.
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.